June 05, 2019 Asco 2019 event analyser – low-key meeting belies some huge stock moves Mirati Therapeutics nearly stole the show at Asco despite not actually presenting – a fact that illustrates how low on meaningful data this year's conference was.
October 17, 2018 Pre-Esmo jitters for Roche Discontinuations and an unusual revelation about Tecentriq’s breast cancer data dominated the R&D part of the company’s third-quarter results call.
